Carboplatin activity in cisplatin treated neuroblastoma.
Lewis
I J
IJ
Seacroft Hospital, Leeds.
Stevens
M C
MC
Pearson
A D
AD
Pinkerton
C R
CR
Barnes
J M
JM
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001299:Audiometry; D001853:Bone Marrow / Q000473:pathology; D016190:Carboplatin / Q000627:therapeutic use* / Q000633:toxicity; D002675:Child, Preschool; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000188:drug therapy* / Q000473:pathology; D013713:Teniposide / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D003520:Cyclophosphamide; D013713:Teniposide; D016190:Carboplatin; D002945:Cisplatin